Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Randomized Multicentre Phase I/II Clinical Trial to Evaluate Safety and Efficacy of NOVOCART® Disc Plus Autologous Disc Chondrocyte Transplantation (ADCT) in the Treatment of Nucleotomized and Degenerative Lumbar Discs to Avoid Secondary Disease

NCT01640457 is registered in ClinicalTrials.gov with Tetec AG as lead sponsor.

NCT NCT01640457
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01640457 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Randomized Multicentre Phase I/II Clinical Trial to Evaluate Safety and Efficacy of NOVOCART® Disc Plus Autologous Disc Chondrocyte Transplantation (ADCT) in the Treatment of Nucleotomized and Degenerative Lumbar Discs to Avoid Secondary Disease
Lead sponsor
Tetec AG
Phase
Phase 1/2
Overall status
Completed
Start date
August 31, 2012
Completion date
June 14, 2021
Enrollment
120 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

intervertebral disc degeneration, intervertebral disc displacement